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Objective: To evaluate the diagnostic performance of two polymerase chain reaction (PCR) procedures using skin 
biopsies of 20 erythema migrans (EM) and 24 acrodermatitis chronica atrophicans (ACA) patients. 
Methods: One assay amplified a fragment of the outer surface protein (Osp) A gene. The second method amplified the 
spacer region between the 5s and 23s rRNA genes; hybridization of this fragment allowed identification of Borrelia 
burgdorferi sensu lato species. 
Results: Among EM patients, both assays detected Borrelia DNA in 15 samples. Among ACA patients, the ospA PCR 
detected 15 positives and 10 samples were positive by 5s-23s PCR. In 19 samples one species was detected, 15 skin 
biopsies contained Borrelia afielii, and Borrelia gariniiwas found in two patients. Group VS116 was detected in two EM 
patients, and therefore this group has pathogenic potential. Mixed infections of B. afielii and B. garinii, group VS116 or 
B. burgdorferi sensu stricto were found in three EM and three ACA patients. 
Conclusions: Diagnosis of EM and ACA by PCR is useful and knowledge of the presence of species may be used to 
predict the course of disease or the need for further antibiotics. 
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INTRODUCTION 
In Europe, Lyme borreliosis (LB) is caused by the bite 
of Ixodes ricinus ticks, which transmit a group of diverse 
spirochetes called Borrelia burgdorferi sensu lato [1,2]. 
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B. burgdorferi sensu lato is divided into several species on 
the basis of DNA relatedness as well as other genotypic 
and phenotypic characteristics [3-71. In Europe, three 
species and two genomic groups of B. burgdoferi sensu 
lato have been isolated &om Ixodes ricinus: B. burgdorferi 
sensu stricto, B. garinii, B. afzelii [3,8], Pod32 and VS116 
respectively [9,10]. Clinical manifestations of European 
LB have been associated with three species: acro- 
dermatitis chronica atrophicans (ACA) is thought to be 
caused by B. afielii, whilst B. garinii is associated with 
neurologic symptoms, and arthritis is attributed to B. 
burgdoferi sensu stricto [11,12]. These manifestations 
are often preceded by erythema migrans (EM), a skin 
rash at the site of tick bite [l]. Since clinical manifesta- 
tions of LB are often unclear, laboratory confirmation 
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is required, and for t h s  purpose serology is used. 
However, in the early stage of disease false-negative 
results are fiequently found [13], and the presence of 
antibodies is not always proof of active Borrelia infection 
[14]. The polymerase chain reaction (PCR) can detect 
DNA of Borrelia spp. in patient material and thereby 
establish the presence of the spirochete. In EM and 
ACA patients, the PCR has successfdy been used to 
detect Borrelia DNA in blood [15] and in skin biopsies 
[16-181. Cerebrospinal fluid, serum and urine are 
sources for detection of Borrelia DNA in neuro- 
borreliosis patients [19-231. In Lyme arthritis patients, 
Borrelia DNA has been detected in urine or synovial 
fluid [24,25]. Recently, species of B. burgdorferi sensu lato 
have been identified by PCRs which target the 05pA 
gene. Mixed or single infections by Ifferent species 
have been detected by ospA PCR in ticks [21,26] and 
neuroborreliosis patients [20,21]. Three species were 
found in one ACA patient by analysis of single-strand 
conformational polymorphism of PCR products [27]. 
Previously, the highly polymorphic 5s-23s rRNA 
gene spacer region was used as target for the PCR 
[19,28]. Hybridization of the amplified intergenic 
spacer region in a reverse line blot (RLB) format 
allowed identification of B. burgdo@ri semu lato species 
and mixed infections of species in ticks [lo]. The aim 
of the present study was two-fold: first, to compare the 
performance of the 5s-23s rDNA PCR with that of 
the o5pA PCR; and second, to determine whether 
species other than B. afzelii can be detected in the skin 
lesions of patients with EM and ACA. 
MATERIALS AND METHODS 
Patients and samples 
From January 1989 to July 1994, EM (n=20) and ACA 
(n=24) were diagnosed in patients who were seen by 
one of us (D.T.) at a dermatologic and phlebologic 
practice in a regional hospital located in the province 
of Friesland, The Netherlands (Tables 1 and 2) .  None 
of the patients had received antibiotic treatment prior 
to clinical diagnosis. EM had a size of 5 cm or more at 
presentation. The diagnosis of ACA was made on the 
bases of clinical presentation, histopathologic exami- 
nation of skin biopsies and serologic data. Clinical 
and histopathologic data are described in detail else- 
where [29]. 
Serology 
Indirect immunofluorescence (IFA) [30] was used to 
detect immunoglobulin (Ig) G and IgM in ACA 
patients who were diagnosed &om 1989 to the 
beginning of 1993 (Table 2). Since 1993, an indirect 
enzyme-linked immunosorbent assay (ELISA) (Lyme 
disease microassay, Diamedix Co., Miami, Florida) has 
been used for detection of total Ig to the Borrelia genus, 
and a p-capture flagellum ELISA @ako A/S, Glostrup, 
Denmark) was used for detection of Borrelia antibodies 
Table 1 Detection of infection by Borreliu spp. in EM patients by immunoassays, PCR and RLB 
Patient Age History of Site and duration Result in 
No. Sex (yr) tick bite of EM ELISA ospA PCR 5s-23s PCR and RLB 
1 F 25 Yes Chest, 3 weeks - + - 
2 F 58 Yes Chest, 4 days - - - 
3 F 35 Yes Left knee, 4 weeks IgM+ + Group VSll6 
4 M 54 No Right knee, 3 weeks IgM+ + B. afzelii 
5 M 43 No Left ankle, 2 weeks IgM+ + Group VS116 
B. afzelii 
7 F 49 No Right hip, 3 months - + B. afzeelii/B. gurinii/Group VS116 
8 F 52 Yes Right hip, 6 weeks IgG/M+ + B. afilii 
9 M 50 Yes Right hip, 3 weeks - + B. ajzelii 
10 F 50 No Left hip, 4 months ND + B. afzelii 
+ B. afzelii 
- B. garinii 
B. afzeelii 
15 F 51 Yes Right ankle, 2 weeks - + B. afielii 
17 F 62 Yes Left knee, 4 weeks - + B. &elii/B. garinii/B. bugdo$rn' 
6 F 52 Yes Left shoulder, 6 weeks IgG/M+ + 
- - 11 M 23 Yes Left calf, 3 days I&+ 
12 F 48 No Right hip, 4 weeks IgM+ 
13 F 70 No Left calf, 1 week ND 
14 F 57 No Right ankle, 4 weeks IgM+ + 
16 F 57 No Left calf, 3 month IgG+ - - 
18 F 63 No Left knee, 3 weeks I@+ 
sewu shiao 
+ - 
- B. afeelii/B. garinii/Group VS116 19 F 21 No Left calf, 5 months IgG/M+ 
20 F 60 No Right buttock, not known IgM+ + B. afzeelii 
IgM+=IgM detected; IgG/M+=IgM and IgG detected; ND=not done; IgG+=IgG detected. 
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Table 2 Detection of Borrelia infection in ACA patients by immunoassays, PCR and RLB 
~ _____ _____ 
Patient Age History of Site and durahon Result in 5s-23s PCR 
No. Sex (yr) hck bite/EM of ACA IFA ELISA ospA PCR and RLB 
1 F 
2 F 
3 F 
4 F 
5 F 
6 M 
7 M 
8 F 
9 F 
10 F 
11 M 
12 F 
13 M 
14 F 
15 M 
16 M 
17 F 
18 M 
19 M 
20 F 
21 F 
22 F 
23 F 
24 F 
73 
71 
17 
54 
48 
60 
34 
69 
34 
66 
50 
83 
38 
64 
51 
58 
70 
24 
44 
41 
63 
79 
75 
40 
Yes/No 
No/No 
Yes/Yes 
No/No 
No/No 
No/No 
No/No 
No/No 
Yes/Yes 
No/No 
Yes/Yes 
Yes/Yes 
No/No 
Yes/No 
Yes/Yes 
No/No 
No/No 
No/No 
No/No 
No/No 
No/Yes 
No/No 
No/No 
No/No 
Both legs, 18 months 
Both legs, 6 months 
Four extremities, 6 months 
One leg, 12 years 
Both legs, 10 years 
One leg, 6 months 
One leg, 9 months 
One leg, 7 years 
One leg, 9 months 
One leg, 3 years 
One arm, chest, 3 years 
Four extremities, 8 years 
Four extremities, 15 years 
One leg, 8 years 
One leg, 18 months 
One leg, 2 years 
Two legs, 2 years 
One leg, two arms, 1 year 
One leg, 3 years 
One leg, 6 years 
One leg, 6 years 
One leg, 3 years 
One leg, one hand, 
9 months 
One leg, 3 months 
IgG+ 
lgG/M+ 
ND 
I&+ 
I@+ 
IgG/M+ 
IgG? 
IgG+ 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
IS+ 
I&+ 
I&+ 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
k+ 
k+ 
k+ 
ND 
lgG+ 
Ig+ 
k+ 
k+ 
k+ 
k+ 
k+ 
IgG+ 
ND 
ND 
ND 
I@+ 
Ig+ 
- 
B. afielii/B. garinii 
B. garinii 
B. afielii 
- 
- 
B. afi.elii 
B. afielii 
- 
- 
- 
- 
B. afielii 
B. af+elii/Group VS116 
B. afielii 
- 
- 
- 
- 
B. afzlii 
B. afilii/Group VSll6 
~ ~ ~~~~ ~~ 
IgG+=IgG detected; ND=not done; IgG/M+=IgM and 1gG detected; lg+=Ig detected, no differenhahon between IgM and IgG; 
IgG+IgG level borderhe. 
in serum of ACA and EM patients [13]. Test procedures 
and interpretation of results were carried out as 
described by the manufacturer. 
Preparation of skin biopsies for PCR 
Slun biopsies were taken near the border of the EM, 
and from ACA patients at a site where manifestations 
of disease were evident. Skin was disinfected with an 
aqueous solution of 2% polyvinylpyrrolidone iodine. 
Biopsies were obtained by punch (3 mm), and im- 
medately frozen in liquid nitrogen and stored at 
-80°C. For the PCR, skin biopsies were processed as 
described by Bergmans et al. [31] and DNA was 
extracted by the method of Boom et al. [32]. Briefly, 
100 $ of lysate was mixed with 1 mL of guanidine 
thiocyanate buffer and 40 pL of silica particles. DNA 
was adsorbed to silica particles by continuous mi;dng 
for 30 min, and then the particles were washed 
extensively and dried. DNA was eluted from silica with 
100 pL of H20 at 60°C and supernatant was stored at 
-20°C. A negative sample was included for every five 
patient samples, and samples of phosphate-buffered 
saline (PH 7), spiked with 10, 100 and 1000 spirochetes 
of B. burgdorferi sensu stricto strain B31 (American Type 
Culture Collection no. 35210), were included in each 
run to determine the efficiency of the DNA extraction 
procedure. Immediately before use in the PCR, 
supernatant was incubated for 10 min at 60 "C and spun 
for 2 min. to remove remaining silica particles. Five 
microlitres of the supernatant were used in the PCR. 
Detection of B. burgdotferi sensu lafo by ospA PCR 
Primer sequences and positions have been derived from 
the ospA gene of B. burgdofferi sensu stricto B3 1 [33], and 
are given in Table 3. The ospA gene was detected by 
a nested PCR [15], and the specificity of the PCR 
product was determined by hybridization. For the first 
PCR, 5 pL of extracted DNA was added to 20 pL of 
reaction mix, which contained Super Tth polymerase 
(0.125 U; H T  Biotechnology, Cambridge, UK), 
uracyl-DNA-glycosylase (UDG, 0.05 U, Life Tech- 
nologies, Gibco BRL, Breda, The Netherlands), 
Super Tth reaction buffer (HT Biotechnology) supple- 
mented with 2.5 mM MgC12, dNTPs (100 pM dTTP, 
100 p M  dUTP, and 200 pM dATP, dGTP and dCTP; 
Boehringer Mannheim, Mannheim, Germany), and 
5pmol each of primers (Isogen, Amsterdam, The 
Netherlands) OspA-N1 and OspA-C1. PCR was 
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Table 3 Primers and probes used for the detection and identification of B. burgdorfni $emu lato species 
Designation 
~ ~~ ~ 
Nucleotide sequence 
~ ~~ 
Nucleotide position on target DNA 
~ _ _ _ _  ~ 
Primea for ospA' PCR I 
OspA-N1 5'GAGCTTAAAGGAACTTCTGATAA 
OspA-C1 5 ' GTATTGTTGTACTGTAATTGT 
Primers for ospA' PCR I1 
OspA-N2 5'ATGGATCTGGAGTACTTGAA 
OSPA-C~ 5 'CTTAAAGTAACAGTTCCTTCT 
334-356 
894-874 
362-381 
713-693 
Probe for hybridmtion of ospA' 
PCR product 
BB6 5 'Digoxigenin- ACTAATGTTTTGCCATCTTCTTTGAA 449424 
Primers for 5s-23s intergenic 
spacerb PCR I 
23SN1 5'ACCATAGACTCTTATTACTTTGAC 
23SC1 5'TAAGCTGACTUTACTAATTACCC 
Primers for 5s-23s intergenic 
space$ PCR I1 
23SN2 5 ' ACCATAGACTCTTATTACTTTGACCA 
5SCB 5'Biotin-GAGAGTAGGTTATTGCCAGGG 
469-446 
92-1 15 
469-444 
243-263 
Probes for hybridization of 5s-23s 
intergenic spacerb.c PCR product 
B. burgdotfen' semu lato 5' a-CTTTG ACCATATTTTTATCTTCCAd 453-430 
B. burgdotfm' sensu strict0 5'a-AACACCAATATTTAAAAAACATAA 322-299 
322-298 B. gorinii 5 'a- AACATGAACATCTAAAAACATAAA 
B. afieli i  5'a-AACATTTAAAAAATAAATTCAAGG 305-278 
Group VS116 5 'a-CATTAAAAAAATATtlAAAAATATAAAAAATAAATTTAAGG 303-278 
'Positions and sequences of the prlmers and probe of the B. burgdofen' semu strict0 B31 ospA gene are derived from Bergstrom et al. [33] 
bPositiom and sequences of the primers and probe positions on the 5s-23s intergenic spacer are derived h m  Schvmtz et al. [28]. 
'Sequences of the probes were obtained &om Postic et al. [9]. 
da=aminolink spacer. 
performed in a thermal cycler (Thermocycler 480, 
Perlun-Elmer, Gouda, The Netherlands). The initial 
incubation of 5 min at 37°C removed any contamina- 
tion by previous PCR products, and was followed by 
denaturation (10 min at 94OC) and 30 rounds of 
temperature cycling (94°C for 1 min, 45°C for 1 min, 
and 72 O C  for 1 min, the DNA amphfkation step being 
extended for 5 s with each cycle). Samples were kept 
at 72°C and finally put on ice. Two microlitres of the 
first PCR were added to the mix €or the second PCR. 
This reaction mix contained the same ingredents as the 
first PCR mix except for UDG and the primers, which 
were replaced by ospA-N2 and ospA-C2 (Isogen). 
DNA was amplified by 35 rounds of temperature 
cycling and the annealing temperature was set at 43 "C. 
Samples were kept at 72°C for at least 6 min, and 
finally samples were stored at -20°C. Efficiency of 
DNA amplification was checked with three controls 
which contained 1, 10 and 100 fg of DNA of B. 
burgdor+ri senm stricfo B31. DNA amplification by the 
second PCR was also monitored separately by controls 
which contained 400, 40 and 4 pg of 1331 DNA. Ten 
microlitres of the second PCR mixture were examined 
by electrophoresis on ethidium-bromide-stained 2% 
agarose gels and Southern blotting. The specificity of 
the 352-bp PCR product was confirmed by overnight 
hybridization at 5OoC with a digoxigenin-labeled 
probe BB6 (Isogen), and bound probe was detected 
using the DIG nucleic acid detection kit Poehringer 
Mannheim). Samples &om patients who were negative 
by PCR were spiked with 50% of B31 DNA 
(approximately 10 genome equivalents) to determine 
whether PCR was inhibited by components in the 
DNA extract of the slun biopsy. The ospA genes of 
representatives of B. afzezii, B. garinii, B. burgdorferi sensu 
strict0 and group VS116 were detected by this PCR 
(results not shown). 
Identification of B. burgdorferi sensu lato species by 
hybridization of the amplified intergenic spacer region 
between the 5s and 23s rRNA genes 
Primers and probes and the sensitivity and specificity of 
the nested 5s-23s PCR and the RLB for the detection 
and identification of genomic groups of B. burgdo$eri 
sensu Zuto have been described previously [9,10,28]. 
Sequences and positions of the primers and the probes 
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are given in Table 3. In this study, we modified the 
PCR procedure. Five microlitres of the first PCR 
were added to 20 FL of the reaction mixture of the 
second PCR, which consisted of 0.625 U of Taq 
DNA polymerase (Perkin-Elmer), Saiki buffer (Perkin- 
Elmer) supplemented with 2.5 mM MgCL, dNTPs, 
and 5 pmol each of biotin-labeled primer 5SCB and 
primer 23SN2 (Perkin-Elmer). The sensitivity of the 
5s-23s PCR in patient material was checked with a 
DNA dilution range (1 to 100 fg) which was also used 
to determine the sensitivity of the ospA PCR. Samples 
from patients who were negative by PCR were spiked 
with 50 fg of B31 DNA (approximately 10 genome 
equivalents) to determine whether PCR was inhibited 
by components in the DNA extract of the skin biopsy. 
Samples were analyzed by agarose gel electrophoresis, 
and, when amplified DNA was present, the sample was 
hybridized in the RLB to identify the species or 
genomic group of B. burgdorferi sensu lato [lo]. 
Statistical analysis 
The Fisher’s exact test (two-tailed) of the package 
GraphPad Instat (version 1.14, GraphPad Software, San 
Diego, CA) was used to compare results between the 
PCRS. 
RESULTS 
Sera and skin biopsies of patients with EM or ACA 
were investigated by PCR, RLB and immunoassays. 
The results are summarized in Tables 1 and 2. A 
selection of PCR products obtained &om skin biopsies 
and hybridized in the RLB is shown in Figure 1. 
Comparison of the ospA PCR and the 5s-23s PCR 
The sensitivities of the ospA PCR and the 5s-23s PCR 
were determined with a dilution range of purified B31 
DNA which originated from one batch. Both PCRs 
detected one genome equivalent (1 to 5 fg) diluted in 
water (results not shown). The ospA PCR and the 
5s-23s PCR both detected Borrelia DNA in 15 of 20 
EM patient samples (75%). Discrepant PCR results 
were found. Two EM patients were positive by 5s-23s 
PCR only, and two were positive by ospA PCR only. 
In four seronegative EM patients, the presence of 
Borrelia spp. was confirmed by PCR. 
The ospA PCR detected Borrelia DNA in skin 
biopsies of 15 of 24 (63%) ACA patients. Ten (42%) 
ACA patients were positive by 5s-23s PCR. In one 
ACA patient Borrelia DNA was detected only by the 
5s-23s PCR, whereas six ACA patients were positive 
in the ospA PCR and not in the 5s-23s PCR. The 
difference in diagnostic sensitivity between the PCRs 
was not statistically significant (P = 0.25). Samples of 
skin biopsies which were negative in the 5s-23s PCR 
(n=19) or the ospA PCR (n=14) were spiked with 50 
fg of Borrelia DNA and were subsequently found 
positive by PCR (results not shown). 
Identification of B. burgdorferi sensu /at0 species in skin 
biopsies 
Hybridization of 5s-23s PCR products showed that 
one species of B. burgdorferi sensu lato was present in a 
total of 19 samples (Tables 1 and 2). In 15 of these 
samples B. afzlii was detected; nine samples originated 
&om EM patients. B. garinii was detected in one EM 
patient and in one ACA patient, and group VS116 was 
1 2 S 4 5 6 7 8 9 10 11 12 1314 15 1617 1619 20 2122 23 242526 
6.burgidorfgn’ semu id0 a *  m 4 
8.gc~idi .- I) 
B.ahedu m * 
Group VSll6 m a 
B.bureorteti sensustrscf~ 
Figure 1 Identification of species of B. burgdorferi sensu lato in skin biopsies of EM and ACA patients. Isolates of Borrelia spp. 
(positive controls) in lanes 1 to 4, and patient samples in lanes 5 to 26. Lane 1: B. afielii, strain M9S. Lane 2: B. burgdorferi 
semu stricto, strain B31. Lane 3: group VS116, strain AR-2. Lane 4: B. garinii, strain &-I. Lanes 5 to 20: ACA patients. 
Lanes 21 to 26: EM patients. Lanes 5, 15 and 24: skin biopsies which contain more than one species. 
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found in two EM patients. Mixed infections were 
found in three EM and three ACA patients. Among 
EM patients, mixed infections consisted of three 
species, and ACA patients had infections with two 
species. The duration of ACA in the patients who had 
mixed infections ranged from 6 months to 3 years. 
Mixed infections always contained B. afielii and either 
group VS116 or B. gurinii. B. burgdorferi sensu stricto was 
detected once as part of a mixed infection in an EM 
patient. 
Serology 
Borrelia antibodies were detected in 12 of 18 EM 
patients (67%), and nine sera contained IgM. Borreliu- 
specific antibodies were detected in 22 of 23 ACA 
patients (96%); one serum sample (Table 2, patient 7) 
contained borderline levels of anti-Borrefia IgG, and 
IgM reactivity was found in two of 12 patients (17%). 
DISCUSSION 
We investigated 44 skin biopsies of EM and ACA 
patients to evaluate the performance of the 5S-23s 
rDNA spacer PCR and the ospA PCR. Both PCRs 
detected Borrelia DNA in an equal number of EM 
patients, whereas among ACA patients diagnostic 
sensitivity of ospA PCR (63%) was hgher than that of 
the 5S-23s PCR (42%). In comparison with serology, 
both PCRs had additional value for the confirmation 
of patients diagnosed as having EM, whereas serologic 
analysis confirmed nearly all cases of ACA. In this study 
we report one case (Table 2, patient 7) where diagnosis 
of ACA was confirmed by PCR only. This patient had 
a bluish discoloration with slight edema around the 
ankle and leg, and histopathologic examination of 
the subepidermis showed a characteristic band-like 
infitration of lymphocytes [30]. All clinical signs dis- 
appeared after antibiotic treatment. 
Our findings are supported by studies of others 
who compared PCR and conventional methods for 
laboratory diagnosis of EM and ACA patients. Among 
EM patients, detection of Borreliu spirochetes by PCR 
proved to be more sensitive than culture [17,18], 
serology [17] and microscopy [16]. Moter et al. [17] 
reported a higher sensitivity for the ospA PCR for 
diagnosis of ACA patients and EM patients than we 
show here. The lower diagnostic sensitivity of the ospA 
PCR described in the present study may be attributed 
to differences in PCR components (e.g. origin of Taq 
DNA polymerase), procedures for sample preparation 
or selection of primers. Our primers were able to 
a m p w  the ospA gene of the same species as investi- 
gated by Moter et al., and spiking of PCR-negative 
samples did not reveal the presence of PCR inhibitors. 
Therefore, the procedure used for sample preparation 
may be an important factor. Prior to isolation of total 
DNA, Moter et al. enriched the skin biopsy for Borreliu 
spirochetes by a prolonged incubation in Barbour- 
Stoenner-Kelly I1 medium, while we isolated DNA 
directly from the skin biopsy, without enrichment, and 
we extracted the DNA by adsorption to a silica matrix. 
Nearly all DNA in a mgested skin biopsy sample will 
be of human origin, and competition for a binding site 
on the matrix may result in under-representation 
of the Borrelia DNA in the processed sample. These 
differences in the DNA extraction procedure could 
lead to the lower sensitivity of our ospA PCR assay. 
In the present study we observed a lower sensitivity 
for the 5S-23s PCR than for the ospA PCR among 
ACA patients. The copy numbers of both PCR targets, 
which reside on a linear plasmid and the chromosome 
respectively, are similar for low-passage B. burgdorferi 
sensu stricto isolate B31 [34]. The discrepancy between 
the outcome of both PCRs may therefore be explained 
by the use of different DNA polymerases and buffers. 
Hybridization of 5S-23s PCR products showed 
that apart from B. afielii, mixed infections of B. afzelii 
and B. gurinii or group VS 11 6 occurred fiequently in 
EM and ACA patients. All species reported here have 
been found in Dutch Ixodes rin'nus [10,12,35]. B. afielii 
was present in 90% of PCR-positive skin biopsies fiom 
ACA patients. The association of B. afielii and ACA has 
been noted previously [8,11]. The abundant presence 
of B. ufzelii in skin biopsies of Dutch EM and ACA 
patients may also be explained by a predominance of B. 
afielii in Dutch Ixodes ticks or a tropism of B. afielii to 
low-temperature areas of the body. Mixed infections, 
which always contained B. afielii, were found in 24% 
of PCR-positive patients. Previously, three species have 
been detected simultaneously in one ACA patient [27], 
and mixed infections of B. garinii and another species 
have been reported in neuroborreliosis patients [20]. 
The presence of multiple species in biopsies and 
biological fluids of LB patients is not surprising. Ixodes 
ricinus ticks [10,21,26,36] and competent reservoirs like 
small rodents [37] can carry infections with multiple 
species. The detection of mixed infections by PCR 
seems to be in contradiction to the observation that 
spirochetes isolated fiom ticks and LB patients by 
culture contain only one species [6]. However, culture 
procedures, which often include antibiotics, may 
inadvertently select for only one species [12], one 
species may dominate other species in patient material, 
or one species may adapt best to culture in vitro. 
In one EM patient and one ACA patient only B. 
garinii was detected. B. gurinii has been isolated h m  
skin lesions of EM patients, and these lesions resolve 
more quickly than those caused by infection with B. 
R i j p k e m a  e t  a l :  B. b u r g d o r f e r i  s e n s u  str icto i n  s k i n  b i o p s i e s  115 
ufzelii [12]. Mild neurologic complaints are sometimes 
found in ACA patients [38]; however, the ACA patient 
described in this study did not have any symptoms of 
neuropathy. Detection of group VS116 alone in skin 
lesions of EM patients is intriguing and inmcates that 
group VS116 has pathogenic potential. 
In conclusion, rapid identification of B. burgdorferi 
sensu lufo species in skin biopsies is a valuable tool for 
the laboratory diagnosis of EM or ACA. B. afielii could 
be identified in nearly all ACA patients, which 
confirms the close association of this species with 
chronic cutaneous LB. Mixed infections were regularly 
detected in EM patients as well as in ACA patients. 
Although reinfections by separate tick bites cannot be 
excluded, the presence of multiple species in lesions of 
EM and ACA patients may reflect the occurrence of 
mixed infections in the local tick populations, and 
shows that infections with multiple species can persist 
for a prolonged period. Whether all species which are 
detected by PCR in mixed infections contribute 
substantially to the development or severity of clinical 
manifestations of LB remains to be clarified. In EM 
patients, the presence of different species may have an 
effect on the course and severity of disease. Thus 
identification of the species of B. burgdorferi sensu lato in 
patients who are in the early stage of disease can provide 
important information concerning the need for further 
antibiotic treatment. 
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